EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FGFR1-driven brachyury promotes endothelial-like differentiation of glioblastoma stem cells via SOX2/ZEB1/YAP1 signaling pathways

Yunping Hu, Bryan T Mott, Wenzhong Yang, Fei Xing, Zhiyong Deng, Wesley Hsu

Cellular Signalling · 2027-02 · 150 · 112986

DOI: 10.1016/j.cellsig.2026.112986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-02. Verfasst von Yunping Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Electronic add…. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wake Forest Clinical and Translational Science Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is characterized by intensive vascular proliferation that is essential for tumor growth. Recent studies indicate the existence of tumor-derived endothelial-like cells can arise from the differentiation of GBM stem cells (GSCs). The transcription factor brachyury plays a critical role in promoting stem cell identity and vasculogenesis during normal embryonic development. However, its involvement in endothelial-like differentiation of GSCs remains unknown. By integrating clinical bioinformatics from GBM databases with preclinical in vitro and in vivo models, including patient-derived GSC cell lines and xenografts, we found that brachyury is highly expressed in GBM tissues and correlates with angiogenesis genes. Our study demonstrated that brachyury is activated by fibroblast growth factor receptor 1 (FGFR1), which subsequently promotes GSC differentiation into endothelial-like cells via SOX2/ZEB1/YAP1 signaling. GSCs with high brachyury expression display great sensitivity to selective FGFR inhibitors in vascular tube formation assays. In vivo pharmacological targeting of FGFR1 with inhibitor E7090 or brachyury gene editing using Cas9/gRNA suppresses GBM neovascularization and tumor growth. Furthermore, gene signature analysis of GBM patients further demonstrated that a lower FGFR1/brachyury/SOX2/ZEB1/YAP1 signature score significantly correlates with favorable overall survival outcomes. These findings highlight the importance of FGFR1-driven brachyury activation in GSC-derived neovascularization and suggest that targeting the FGFR1-directed brachyury/SOX2/ZEB1/YAP1 signaling represents a promising therapeutic strategy for GBM.

Schlagwörter

Stichwörter der Autor:innen

BrachyuryEndothelial-like differentiationFibroblast growth factor receptor 1GBM stem cellsGlioblastoma

Autor:innen und Institutionen

  • Department of Neurological Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Electronic address: Yunping.Hu@advocatehealth.org.
  • Department of Neurological Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
  • Department of Internal Medicine-Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
  • Department of Cancer Biology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
  • Department of Translational Neuroscience, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
  • Department of Neurological Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Electronic address: Wesley.Hsu@advocatehealth.org.

Förderung

  • Wake Forest Clinical and Translational Science Institute

Zitieren

APA

Hu, Y., Mott, B. T., Yang, W., Xing, F., Deng, Z., & Hsu, W. (2027). FGFR1-driven brachyury promotes endothelial-like differentiation of glioblastoma stem cells via SOX2/ZEB1/YAP1 signaling pathways. Cellular Signalling, 150, 112986. https://doi.org/10.1016/j.cellsig.2026.112986

Vancouver

Hu Y, Mott BT, Yang W, Xing F, Deng Z, Hsu W. FGFR1-driven brachyury promotes endothelial-like differentiation of glioblastoma stem cells via SOX2/ZEB1/YAP1 signaling pathways. Cellular Signalling. 2027;150:112986. doi:10.1016/j.cellsig.2026.112986

BibTeX
@article{Hu2027,
  author = {Hu, Yunping and Mott, Bryan T and Yang, Wenzhong and Xing, Fei and Deng, Zhiyong and Hsu, Wesley},
  title = {FGFR1-driven brachyury promotes endothelial-like differentiation of glioblastoma stem cells via SOX2/ZEB1/YAP1 signaling pathways},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {150},
  pages = {112986},
  doi = {10.1016/j.cellsig.2026.112986}
}
Kostenlos starten →